The DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index.
Risk-Based lung cancer screening: A systematic review
Abstract
Lung cancer remains the leading cause of cancer related deaths worldwide. Lung cancer screening using low-dose computed tomography (LDCT) has been shown to reduce lung cancer specific mortality. In 2013, the United States Preventive Services Task Force (USPSTF) recommended annual lung cancer screening with LDCT for smokers aged between 55 years to 80 years, with at least 30 pack-years of smoking exposure that currently smoke or who have quit smoking within 15 years. Risk-based lung cancer screening is an alternative approach that defines screening eligibility based on the personal risk of individuals. Selection of individuals for lung cancer screening based on their personal lung cancer risk has been shown to improve the sensitivity and specificity associated with the eligibility criteria of the screening program as compared to the 2013 USPSTF criteria. Numerous risk prediction models have been developed to estimate the lung cancer risk of individuals incorporating sociodemographic, smoking, and clinical risk factors associated with lung cancer, including age, smoking history, sex, race/ethnicity, personal and family history of cancer, and history of emphysema and chronic obstructive pulmonary disease (COPD), among others. Some risk prediction models include biomarker information, such as germline mutations or protein-based biomarkers as independent risk predictors, in addition to clinical, smoking, and sociodemographic risk factors. While, the majority of lung cancer risk prediction models are suitable for selecting high-risk individuals for lung cancer screening, some risk models have been developed to predict the probability of malignancy of screen-detected solidary pulmonary nodules or to optimize the screening frequency of eligible individuals by incorporating past screening findings. In this systematic review, we provide an overview of existing risk prediction models and their applications to lung cancer screening. We discuss potential strengths and limitations of lung cancer screening using risk prediction models and future research directions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Siegel, R. L., Miller, K. D., & Jemal, A. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21551 · Cited by 20,160
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
The National Lung Screening Trial Research Team (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102873 · Cited by 11,064
Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial
de Koning, H. J., van der Aalst, C. M., de Jong, P. A., Scholten, E. T., Nackaerts, K., Heuvelmans, M. A., Lammers, J.-W. J., Weenink, C., Yousaf-Khan, U., Horeweg, N., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1911793 · Cited by 3,624
Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation Statement
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2014) · Annals of Internal Medicine · doi:10.7326/m13-2771 · Cited by 2,632
Probability of Cancer in Pulmonary Nodules Detected on First Screening CT
McWilliams, A., Tammemagi, M. C., Mayo, J. R., Roberts, H., Liu, G., Soghrati, K., Yasufuku, K., Martel, S., Laberge, F., Gingras, M., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1214726 · Cited by 1,414
Reducing and meta-analysing estimates from distributed lag non-linear models
Gasparrini, A., & Armstrong, B. (2013) · BMC Medical Research Methodology · doi:10.1186/1471-2288-13-1 · Cited by 1,081
Selection Criteria for Lung-Cancer Screening
Tammemägi, M. C., Katki, H. A., Hocking, W. G., Church, T. R., Caporaso, N., Kvale, P. A., Chaturvedi, A. K., Silvestri, G. A., Riley, T. L., Commins, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211776 · Cited by 1,029
Swensen, S. J. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440290031002 · Cited by 810
American Cancer Society lung cancer screening guidelines
Wender, R., Fontham, E. T. H., Barrera, E., Colditz, G. A., Church, T. R., Ettinger, D. S., Etzioni, R., Flowers, C. R., Scott Gazelle, G., Kelsey, D. K., et al. (2013) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21172 · Cited by 723
Variations in Lung Cancer Risk Among Smokers
Bach, P. B., Kattan, M. W., Thornquist, M. D., Kris, M. G., Tate, R. C., Barnett, M. J., Hsieh, L. J., & Begg, C. B. (2003) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/95.6.470 · Cited by 642
Lung Cancer Screening, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology
Wood, D. E., Kazerooni, E. A., Baum, S. L., Eapen, G. A., Ettinger, D. S., Hou, L., Jackman, D. M., Klippenstein, D., Kumar, R., Lackner, R. P., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0020 · Cited by 611
Jaklitsch, M. T., Jacobson, F. L., Austin, J. H. M., Field, J. K., Jett, J. R., Keshavjee, S., MacMahon, H., Mulshine, J. L., Munden, R. F., Salgia, R., et al. (2012) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2012.05.060 · Cited by 608
European position statement on lung cancer screening
Oudkerk, M., Devaraj, A., Vliegenthart, R., Henzler, T., Prosch, H., Heussel, C. P., Bastarrika, G., Sverzellati, N., Mascalchi, M., Delorme, S., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30861-6 · Cited by 587
Targeting of Low-Dose CT Screening According to the Risk of Lung-Cancer Death
Kovalchik, S. A., Tammemagi, M., Berg, C. D., Caporaso, N. E., Riley, T. L., Korch, M., Silvestri, G. A., Chaturvedi, A. K., & Katki, H. A. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301851 · Cited by 575
Horeweg, N., van Rosmalen, J., Heuvelmans, M. A., van der Aalst, C. M., Vliegenthart, R., Scholten, E. T., ten Haaf, K., Nackaerts, K., Lammers, J.-W. J., Weenink, C., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70389-4 · Cited by 526
The LLP risk model: an individual risk prediction model for lung cancer
Cassidy, A., Myles, J. P., van Tongeren, M., Page, R. D., Liloglou, T., Duffy, S. W., & Field, J. K. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604158 · Cited by 490
Gould, M. K., Ananth, L., & Barnett, P. G. (2007) · Chest · doi:10.1378/chest.06-1261 · Cited by 439
A Risk Model for Prediction of Lung Cancer
Spitz, M. R., Hong, W. K., Amos, C. I., Wu, X., Schabath, M. B., Dong, Q., Shete, S., & Etzel, C. J. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk153 · Cited by 417
Clinical Prediction Model To Characterize Pulmonary Nodules
Herder, G. J., van Tinteren, H., Golding, R. P., Kostense, P. J., Comans, E. F., Smit, E. F., & Hoekstra, O. S. (2005) · Chest · doi:10.1378/chest.128.4.2490 · Cited by 387
Tammemägi, M. C., Church, T. R., Hocking, W. G., Silvestri, G. A., Kvale, P. A., Riley, T. L., Commins, J., & Berg, C. D. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001764 · Cited by 358
Mendelson, M. M., Marioni, R. E., Joehanes, R., Liu, C., Hedman, Å. K., Aslibekyan, S., Demerath, E. W., Guan, W., Zhi, D., Yao, C., et al. (2017) · PLOS Medicine · doi:10.1371/journal.pmed.1002215 · Cited by 350
Gurney, J. W. (1993) · Radiology · doi:10.1148/radiology.186.2.8421743 · Cited by 343
Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening
Katki, H. A., Kovalchik, S. A., Berg, C. D., Cheung, L. C., & Chaturvedi, A. K. (2016) · JAMA · doi:10.1001/jama.2016.6255 · Cited by 338
Tammemagi, C. M., Pinsky, P. F., Caporaso, N. E., Kvale, P. A., Hocking, W. G., Church, T. R., Riley, T. L., Commins, J., Oken, M. M., Berg, C. D., et al. (2011) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djr173 · Cited by 310
ten Haaf, K., Jeon, J., Tammemägi, M. C., Han, S. S., Kong, C. Y., Plevritis, S. K., Feuer, E. J., de Koning, H. J., Steyerberg, E. W., & Meza, R. (2017) · PLOS Medicine · doi:10.1371/journal.pmed.1002277 · Cited by 284
Self-citationCrosbie, P. A., Balata, H., Evison, M., Atack, M., Bayliss-Brideaux, V., Colligan, D., Duerden, R., Eaglesfield, J., Edwards, T., Elton, P., et al. (2019) · Thorax · doi:10.1136/thoraxjnl-2017-211377 · Cited by 242
Evaluation of USPSTF Lung Cancer Screening Guidelines Among African American Adult Smokers
Aldrich, M. C., Mercaldo, S. F., Sandler, K. L., Blot, W. J., Grogan, E. L., & Blume, J. D. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2019.1402 · Cited by 230
Tammemagi, M. C., Schmidt, H., Martel, S., McWilliams, A., Goffin, J. R., Johnston, M. R., Nicholas, G., Tremblay, A., Bhatia, R., Liu, G., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30597-1 · Cited by 216
Hippisley-Cox, J., & Coupland, C. (2012) · British Journal of General Practice · doi:10.3399/bjgp12x616355 · Cited by 208
Patz, E. F., Greco, E., Gatsonis, C., Pinsky, P., Kramer, B. S., & Aberle, D. R. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00621-x · Cited by 184
Katki, H. A., Kovalchik, S. A., Petito, L. C., Cheung, L. C., Jacobs, E., Jemal, A., Berg, C. D., & Chaturvedi, A. K. (2018) · Annals of Internal Medicine · doi:10.7326/m17-2701 · Cited by 184
Risk of malignancy in pulmonary nodules: A validation study of four prediction models
Al-Ameri, A., Malhotra, P., Thygesen, H., Plant, P. K., Vaidyanathan, S., Karthik, S., Scarsbrook, A., & Callister, M. E. J. (2015) · Lung Cancer · doi:10.1016/j.lungcan.2015.03.018 · Cited by 181
Raji, O. Y., Duffy, S. W., Agbaje, O. F., Baker, S. G., Christiani, D. C., Cassidy, A., & Field, J. K. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-4-201208210-00004 · Cited by 181
Hippisley-Cox, J., & Coupland, C. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-007825 · Cited by 175
Assessment of Lung Cancer Risk on the Basis of a Biomarker Panel of Circulating Proteins
Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Consortium for Early Detection of Lung Cancer, Guida, F., Sun, N., Bantis, L. E., Muller, D. C., Li, P., Taguchi, A., Dhillon, D., Kundnani, D. L., Patel, N. J., et al. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.2078 · Cited by 169
Silvestri, G. A., Tanner, N. T., Kearney, P., Vachani, A., Massion, P. P., Porter, A., Springmeyer, S. C., Fang, K. C., Midthun, D., Mazzone, P. J., et al. (2018) · Chest · doi:10.1016/j.chest.2018.02.012 · Cited by 165
Solitary Pulmonary Nodules: Clinical Prediction Model Versus Physicians
Swensen, S. J., Silverstein, M. D., Edell, E. S., Trastek, V. F., Aughenbaugh, G. L., Ilstrup, D. M., & Schleck, C. D. (1999) · Mayo Clinic Proceedings · doi:10.4065/74.4.319 · Cited by 161
An Expanded Risk Prediction Model for Lung Cancer
Spitz, M. R., Etzel, C. J., Dong, Q., Amos, C. I., Wei, Q., Wu, X., & Hong, W. K. (2008) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0060 · Cited by 160
de-Torres, J. P., Wilson, D. O., Sánchez-Salcedo, P., Weissfeld, J. L., Bertó, J., Campo, A., Alcaide, A. B., García‐Granero, M., Celli, B. R., & Zulueta, J. J. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201407-1210oc · Cited by 158
ten Haaf, K., Tammemägi, M. C., Bondy, S. J., van der Aalst, C. M., Gu, S., McGregor, S. E., Nicholas, G. A., de Koning, H. J., & Paszat, L. F. (2017) · PLoS Medicine · doi:10.1371/journal.pmed.1002225 · Cited by 147
Schultz, E. M., Sanders, G. D., Trotter, P., Patz, E. F., Silvestri, G. A., Owens, D. K., & Gould, M. K. (2007) · Thorax · doi:10.1136/thx.2007.084731 · Cited by 141
Muller, D. C., Johansson, M., & Brennan, P. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.69.2467 · Cited by 129
Development and Validation of a Lung Cancer Risk Prediction Model for African-Americans
Etzel, C. J., Kachroo, S., Liu, M., D'amelio, A. M., Dong, Q., Coté, M. L., Wenzlaff, A. S., Hong, W. K., Greisinger, A. J., Schwartz, A. G., et al. (2008) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0082 · Cited by 125
Multistage Carcinogenesis and Lung Cancer Mortality in Three Cohorts
Hazelton, W. D., Clements, M., & Moolgavkar, S. H. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0756 · Cited by 122
Criss, S. D., Cao, P., Bastani, M., ten Haaf, K., Chen, Y., Sheehan, D. F., Blom, E. F., Toumazis, I., Jeon, J., de Koning, H. J., et al. (2019) · Annals of Internal Medicine · doi:10.7326/m19-0322 · Cited by 122
Self-citationA Risk Model for Lung Cancer Incidence
Hoggart, C. J., Brennan, P., Tjønneland, A. M., Vogel, U. B., Overvad, K., Østergaard, J. N., Kaaks, R., Canzian, F., Boeing, H., Steffen, A., et al. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0237 · Cited by 120
Maisonneuve, P., Bagnardi, V., Bellomi, M., Spaggiari, L., Pelosi, G., Rampinelli, C., Bertolotti, R., Rotmensz, N., Field, J. K., DeCensi, A., et al. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0026 · Cited by 119
Jin, C., Cao, J., Cai, Y., Wang, L., Liu, K., Shen, W., & Hu, J. (2016) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2016.10.019 · Cited by 111
Li, K., Hüsing, A., Sookthai, D., Bergmann, M. M., Boeing, H., Becker, N., & Kaaks, R. (2015) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-14-0424 · Cited by 107
A Comparative Modeling Analysis of Risk-Based Lung Cancer Screening Strategies
ten Haaf, K., Bastani, M., Cao, P., Jeon, J., Toumazis, I., Han, S. S., Plevritis, S. K., Blom, E. F., Kong, C. Y., Tammemägi, M. C., et al. (2019) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djz164 · Cited by 107
Self-citationRisk-Targeted Lung Cancer Screening
Kumar, V., Cohen, J. T., Klaveren, D. V., Soeteman, D. I., Wong, J. B., Neumann, P. J., & Kent, D. M. (2018) · Annals of Internal Medicine · doi:10.7326/m17-1401 · Cited by 106
Pro–Surfactant Protein B As a Biomarker for Lung Cancer Prediction
Sin, D. D., Tammemägi, M. C., Lam, S. C., Barnett, M. J., Duan, X., Tam, A., Auman, H. J., Feng, Z., Goodman, G. E., Hanash, S., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.50.6105 · Cited by 105
Massion, P. P., Healey, G. F., Peek, L. J., Fredericks, L., Sewell, H. F., Murray, A., & Robertson, J. F. R. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.08.143 · Cited by 100
Tammemägi, M. C., ten Haaf, K., Toumazis, I., Kong, C. Y., Han, S. S., Jeon, J., Commins, J. M., Riley, T., & Meza, R. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.0204 · Cited by 100
Self-citationA Prediction Model for Lung Cancer Diagnosis that Integrates Genomic and Clinical Features
Beane, J., Sebastiani, P., Whitfield, T. H., Steiling, K. A., Dumas, Y.-M., Lenburg, M. E., & Spira, A. E. (2008) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0011 · Cited by 99
Application of Risk Prediction Models to Lung Cancer Screening: A Review
Tammemägi, M. C. (2015) · Journal of Thoracic Imaging · doi:10.1097/rti.0000000000000142 · Cited by 95
Weber, M. F., Yap, S., Goldsbury, D. E., Manners, D., Tammemägi, M. C., Marshall, H., Brims, F., McWilliams, A. M., Fong, K. M., Kang, Y. J., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.30673 · Cited by 95
Hippisley‐Cox, J., & Coupland, C. A. C. (2011) · British Journal of General Practice · doi:10.3399/bjgp11x606627 · Cited by 92
The Utility of Nodule Volume in the Context of Malignancy Prediction for Small Pulmonary Nodules
Mehta, H. J., Ravenel, J. G., Shaftman, S. R., Tanner, N. T., Paoletti, L., Taylor, K. K., Tammemägi, M. C., Gómez, M., Nietert, P. J., Gould, M. K., et al. (2013) · CHEST Journal · doi:10.1378/chest.13-0708 · Cited by 90
LLPi: Liverpool Lung Project Risk Prediction Model for Lung Cancer Incidence
Marcus, M. W., Chen, Y., Raji, O. Y., Duffy, S. W., & Field, J. K. (2015) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-14-0438 · Cited by 89
Uthoff, J., Stephens, M. J., Newell, J. D., Hoffman, E. A., Larson, J., Koehn, N., Stefano, F. A. D., Lusk, C. M., Wenzlaff, A. S., Watza, D., et al. (2019) · Medical Physics · doi:10.1002/mp.13592 · Cited by 89
C hina national lung cancer screening guideline with low‐dose computed tomography (2015 version)
Zhou, Q., Fan, Y., Bu, H., Wang, Y., Wu, N., Huang, Y., Wang, G., Wang, X., & Qiao, Y. (2015) · Thoracic Cancer · doi:10.1111/1759-7714.12287 · Cited by 87
Wille, M. M. W., van Riel, S. J., Saghir, Z., Dirksen, A., Pedersen, J. H., Jacobs, C., Thomsen, L. H., Scholten, E. T., Skovgaard, L. T., & van Ginneken, B. (2015) · European Radiology · doi:10.1007/s00330-015-3689-0 · Cited by 83
Iyen, B., Tata, L. J., Baldwin, D., Smith, C. J. P., & Hubbard, R. (2013) · Thorax · doi:10.1136/thoraxjnl-2012-202348 · Cited by 76
Comparison of discriminatory power and accuracy of three lung cancer risk models
D'amelio, A. M., Cassidy, A., Asomaning, K., Raji, O. Y., Duffy, S. W., Field, J. K., Spitz, M. R., Christiani, D. C., & Etzel, C. J. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605759 · Cited by 73
Markaki, M., Tsamardinos, I., Langhammer, A., Lagani, V., Hveem, K., & Røe, O. D. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.03.027 · Cited by 73
A multi-parameterized artificial neural network for lung cancer risk prediction
Hart, G. R., Roffman, D. A., Decker, R. H., & Deng, J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0205264 · Cited by 73
Disparities of National Lung Cancer Screening Guidelines in the US Population
Han, S. S., Chow, E. K. H., ten Haaf, K., Toumazis, I., Cao, P., Bastani, M., Tammemägi, M. C., Jeon, J., Feuer, E. J., Meza, R., et al. (2020) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djaa013 · Cited by 73
Self-citationPredicting Lung Cancer Prior to Surgical Resection in Patients with Lung Nodules
Deppen, S. A., Blume, J. D., Aldrich, M. C., Fletcher, S. A., Massion, P. P., Walker, R. C., Chen, H. C., Speroff, T., Degesys, C. A., Pinkerman, R., et al. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000287 · Cited by 70
Individualized Risk Prediction Model for Lung Cancer in Korean Men
Park, S., Nam, B., Yang, H.-R., Lee, J. A., Lim, H., Han, J. T., Park, I. S., Shin, H., & Lee, J. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054823 · Cited by 70
Validation of a Model of Lung Cancer Risk Prediction Among Smokers
Cronin, K. A., Gail, M. H., Zou, Z., Bach, P. B., Virtamo, J. R. K., & Albanes, D. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj163 · Cited by 69
Wang, X., Zhang, Y., Hao, S., Zheng, L., Liao, J., Ye, C., Xia, M., Wang, O., Liu, M., Weng, C. H., et al. (2019) · Journal of Medical Internet Research · doi:10.2196/13260 · Cited by 68
Feasibility of lung cancer prediction from low-dose CT scan and smoking factors using causal models
Raghu, V. K., Zhao, W., Pu, J., Leader, J. K., Wang, R., Herman, J. G., Yuan, J., Benos, P. V., & Wilson, D. O. (2019) · Thorax · doi:10.1136/thoraxjnl-2018-212638 · Cited by 67
Prediction of lung cancer risk in a Chinese population using a multifactorial genetic model
Li, H., Yang, L., Zhao, X., Wang, J., Qian, J., Chen, H., Fan, W., Liu, H., Li, J., Wang, W., et al. (2012) · BMC Medical Genetics · doi:10.1186/1471-2350-13-118 · Cited by 65
Identification of COPD Patients at High Risk for Lung Cancer Mortality Using the COPD-LUCSS-DLCO
de-Torres, J. P., Marín, J. M., Casanova, C., Pinto-Plata, V., Divo, M. J., Côté, C., Celli, B. R., & Zulueta, J. J. (2015) · CHEST Journal · doi:10.1378/chest.15-1868 · Cited by 64
A gene-based risk score for lung cancer susceptibility in smokers and ex-smokers
Young, R. P., Hopkins, R. J., Hay, B. A., Epton, M., Mills, G., Black, P., Gardner, H. D., Sullivan, R., & Gamble, G. D. (2009) · Postgraduate Medical Journal · doi:10.1136/pgmj.2008.077107 · Cited by 63
Soardi, G., Perandini, S., Motton, M., & Montemezzi, S. (2014) · European Radiology · doi:10.1007/s00330-014-3396-2 · Cited by 62
Selecting lung cancer screenees using risk prediction models—where do we go from here
Tammemägi, M. C. (2018) · Translational Lung Cancer Research · doi:10.21037/tlcr.2018.06.03 · Cited by 61
Raji, O. Y., Agbaje, O. F., Duffy, S. W., Cassidy, A., & Field, J. K. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-09-0141 · Cited by 60
Robbins, H. A., Berg, C. D., Cheung, L. C., Chaturvedi, A. K., & Katki, H. A. (2019) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djz041 · Cited by 59
Chung, K., Mets, O. M., Gerke, P. K., Jacobs, C., den Harder, A. M., Scholten, E. T., Prokop, M., de Jong, P. A., van Ginneken, B., & Schaefer‐Prokop, C. M. (2018) · Thorax · doi:10.1136/thoraxjnl-2017-211372 · Cited by 58
[China National Lung Cancer Screening Guideline with Low-dose Computed Tomography (2023 Version)].
(2023) · PubMed Central · doi:10.3779/j.issn.1009-3419.2023.102.10 · Cited by 58
Predicting Lung Cancer Occurrence in Never-Smoking Females in Asia: TNSF-SQ, a Prediction Model
Chien, L.-H., Chen, C.-H., Chen, T.-Y., Chang, G., Tsai, Y., Hsiao, C., Chen, K.-Y., Su, W., Wang, W., Huang, M., et al. (2019) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-19-1221 · Cited by 57
Development and validation of diagnostic prediction model for solitary pulmonary nodules
Yonemori, K., Tateishi, U., Uno, H., Yonemori, Y., Tsuta, K., Takeuchi, M., Matsuno, Y., Fujiwara, Y., Asamura, H., & Kusumoto, M. (2007) · Respirology · doi:10.1111/j.1440-1843.2007.01158.x · Cited by 54
Predicting Malignancy Risk of Screen-Detected Lung Nodules–Mean Diameter or Volume
Tammemägi, M. C., Ritchie, A., Atkar-Khattra, S., Dougherty, B., Sanghera, C., Mayo, J. R., Yuan, R., Manos, D., McWilliams, A. M., Schmidt, H., et al. (2018) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2018.10.006 · Cited by 54
Ghimire, B., Maroni, R., Vulkan, D., Shah, Z., Gaynor, E., Timoney, M., Jones, L., Arvanitis, R., Ledson, M. J., Lukehirst, L., et al. (2019) · Lung Cancer · doi:10.1016/j.lungcan.2019.05.026 · Cited by 53
Lung Cancer Susceptibility Model Based on Age, Family History and Genetic Variants
Young, R. P., Hopkins, R. J., Hay, B. A., Epton, M., Mills, G., Black, P., Gardner, H. D., Sullivan, R., & Gamble, G. D. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005302 · Cited by 51
Veronesi, G., Maisonneuve, P., Rampinelli, C., Bertolotti, R., Petrella, F., Spaggiari, L., & Bellomi, M. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.08.026 · Cited by 48
El‐Zein, R. A., Lopez, M. S., D'amelio, A. M., Liu, M., Munden, R. F., Christiani, D. C., Su, L., Tejera, P., Zhai, R., Spitz, M. R., et al. (2014) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-0462 · Cited by 48
Benchmarking Lung Cancer Mortality Rates in Current and Former Smokers
Bach, P. B., Elkin, E. B., Pastorino, U., Kattan, M. W., Mushlin, A. I., Begg, C. B., & Parkin, D. M. (2004) · CHEST Journal · doi:10.1378/chest.126.6.1742 · Cited by 48
Personalized Risk Assessment in Never, Light, and Heavy Smokers in a prospective cohort in Taiwan
Wu, X., Wen, C. P., Ye, Y., Tsai, M., Wen, C., Roth, J. A., Pu, X., Chow, W., Huff, C. D., Cunningham, S. A., et al. (2016) · Scientific Reports · doi:10.1038/srep36482 · Cited by 48
Lung Cancer Risk Prediction Using Common SNPs Located in GWAS-Identified Susceptibility Regions
Weissfeld, J. L., Lin, Y., Lin, H.-M., Kurland, B. F., Wilson, D. O., Fuhrman, C. R., Pennathur, A., Romkes, M., Nukui, T., Yuan, J., et al. (2015) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000666 · Cited by 45
The Korean guideline for lung cancer screening
Jang, S. H., Sheen, S. S., Kim, H. Y., Yim, H. W., Park, B. Y., Kim, J. W., Park, I. K., Kim, Y. W., Lee, K. Y., Lee, K. S., et al. (2015) · Journal of Korean Medical Association · doi:10.5124/jkma.2015.58.4.291 · Cited by 38
Tammemägi, M. C., Freedman, M. T., Pinsky, P. F., Oken, M. M., Hu, P., Riley, T. L., Ragard, L. R., Berg, C. D., & Prorok, P. C. (2009) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31819e77ce · Cited by 37
van Riel, S. J., Ciompi, F., Wille, M. M. W., Dirksen, A., Lam, S. C., Scholten, E. T., Rossi, S. E., Sverzellati, N., Naqibullah, M., Wittenberg, R., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185032 · Cited by 37
Marcus, M. W., Duffy, S. W., Devaraj, A., Green, B. A., Oudkerk, M., Baldwin, D., & Field, J. K. (2019) · Thorax · doi:10.1136/thoraxjnl-2018-212263 · Cited by 34
Reid, M., Choi, H., Han, X., et al. (2019) · CHEST Journal · doi:10.1016/j.chest.2019.01.038 · Cited by 31
Qian, D. C., Han, Y., Byun, J., Shin, H. R., Hung, R. J., McLaughlin, J. R., Landi, M. T., Seminara, D., & Amos, C. I. (2016) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-1318 · Cited by 30
Marcus, M. W., Raji, O. Y., Duffy, S. W., Young, R. P., Hopkins, R. J., & Field, J. K. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3499 · Cited by 29
Du, Q., Yan, C., Wu, S., et al. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.01.079 · Cited by 29
Chapter 8: The FHCRC Lung Cancer Model
Hazelton, W. D., Jeon, J., Meza, R., & Moolgavkar, S. H. (2012) · Risk Analysis · doi:10.1111/j.1539-6924.2011.01681.x · Cited by 26
Limited Utility of Pulmonary Nodule Risk Calculators for Managing Large Nodules
Hammer, M. M., Nachiappan, A. C., & Barbosa, E. J. M. (2017) · Current Problems in Diagnostic Radiology · doi:10.1067/j.cpradiol.2017.04.003 · Cited by 26
Kovalchik, S. A., Matteis, S. D., Landi, M. T., Caporaso, N. E., Varadhan, R., Consonni, D., Bergen, A. W., Katki, H. A., & Wacholder, S. (2013) · BMC Medical Research Methodology · doi:10.1186/1471-2288-13-143 · Cited by 24
PL02.02 Lung Cancer Screenee Selection by USPSTF Versus PLCOm2012 Criteria – Interim ILST Findings
Lam, S. C., Myers, R. L., Ruparel, M., Atkar-Khattra, S., Stone, E. C. A., Manser, R. L., McWilliams, A. M., Fogarty, P., Lam, D. C.-L., Yee, J., et al. (2019) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2019.08.055 · Cited by 21
Deng, L., Kimmel, M., Foy, M., Spitz, M. R., Wei, Q., & Gorlova, O. Y. (2008) · International Journal of Cancer · doi:10.1002/ijc.24149 · Cited by 20
Zhao, H., Marshall, H., Yang, I. A., Bowman, R., Ayres, J., Crossin, J., Lau, M., Slaughter, R., Redmond, S., Passmore, L. H., et al. (2016) · British Journal of Radiology · doi:10.1259/bjr.20160016 · Cited by 20
Gu, F., Cheung, L. C., Freedman, N. D., Katki, H. A., & Caporaso, N. E. (2017) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2017.08.001 · Cited by 17
Røe, O. D., Markaki, M., Tsamardinos, I., Lagani, V., Nguyen, O. T. D., Pedersen, J. H., Saghir, Z., & Ashraf, H. (2019) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2019-000512 · Cited by 15
Post-imaging pulmonary nodule mathematical prediction models: are they clinically relevant?
for the COPDGene Investigators, Uthoff, J., Koehn, N., Larson, J., Dilger, S. K. N., Hammond, E., Schwartz, A. G., Mullan, B. F., Sanchez, R., Hoffman, R. M., et al. (2019) · European Radiology · doi:10.1007/s00330-019-06168-x · Cited by 10
Karp, I., Sylvestre, M., Abrahamowicz, M., Leffondré, K., & Siemiatycki, J. (2016) · European Journal of Epidemiology · doi:10.1007/s10654-016-0180-4 · Cited by 7
Hassannezhad, R., & Vahed, N. (2018) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2018.06.009 · Cited by 7
Impact of Tobacco Dependence in Risk Prediction Models for Lung Cancer Diagnoses and Deaths
Ward, R. C., Tanner, N. T., Silvestri, G. A., & Gebregziabher, M. (2019) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkz014 · Cited by 4
Cited by
Milam, M. E., & Koo, C. W. (2023) · Clinical Radiology · doi:10.1016/j.crad.2022.08.135 · Cited by 53
Lin, A., Zhang, H., Meng, H., Deng, Z., Gu, T., Luo, P., & Zhang, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.667875 · Cited by 27
Metadata
- Authors
- Toumazis, I., Bastani, M., Han, S. S., & Plevritis, S. K.
- Venue
- Lung Cancer
- Publisher
- Elsevier BV
- Published
- 2020-09
- Volume
- 147
- Pages
- 154-186
- ISSN
- 0169-5002 (ISSN-L)
- OpenAlex
- W3040813705
- Cited by
- 270
- References
- 113
- FWCI
- 6.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.